"Most view" Articles are updated quarterly. Below are Clin Mol Hepatol’s most frequently accessed articles for the previous last months.
-
Reviews
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- Clin Mol Hepatol. 2023;29(4):851-868.
-
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- Clin Mol Hepatol. 2023;29(4):851-868.
-
Original Articles
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732.
-
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732.
-
Reviews
MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31.
-
MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31.
-
Management of refractory ascites
- Florence Wong
- Clin Mol Hepatol. 2023;29(1):16-32.
-
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
- The Korean Association for the Study of the Liver (KASL)
- Clin Mol Hepatol. 2012;18(2):109-162.
-
Management of refractory ascites
- Florence Wong
- Clin Mol Hepatol. 2023;29(1):16-32.
-
Global incidence and prevalence of nonalcoholic fatty liver disease
- Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
- Clin Mol Hepatol. 2023;29(Suppl):S32-S42.